Skip to main content

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator 

Transaction expands Ligand’s royalty portfolio to more than 200 assets and adds seven new commercial products Bolsters and diversifies Ligand’s long-term compounding growth, adding a complementary portfolio across development stages, therapeutic areas, and modalities to broaden patient access and improve lives Acquisition is expected to be immediately accretive to Ligand adjusted EPS; Ligand increases 2026 adjusted EPS guidance to $8.50-$9.501 and expects the transaction to be accretive by $1.50 per share to adjusted EPS in 20272 Ligand to hold investor call at 8:00 a.m. ET today JUPITER, Fla. and EMERYVILLE, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) and XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), both biotechnology royalty aggregators, today announced that the companies...

Continue reading

Fenix Outdoor International to acquire outstanding minority in Devold

Solna 2026-04-27 Fenix Outdoor International AG, a global leader in the development and sale of premium apparel and equipment for outdoor life has today signed a term sheet with the ambition to acquire the outstanding 35% minority of Devold of Norway AS. Fenix Outdoor holds 65% in Devold of Norway since March 2025. Fenix Outdoor will after an acquisition control 100% of the shares in Devold of Norway. The term sheet states that Fenix Outdoor will pay 9.6 MEUR for the 35% stake in Devold through cash. The seller is the Flakk Group, a Norwegian based family-owned business. An acquisition of these outstanding shares in Devold will further support Fenix Outdoor ability to faster expand the Brand outside its current two most important markets Norway and Germany. The report contains information which Fenix Outdoor International AG is obliged...

Continue reading

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Transaction expands Ligand’s royalty portfolio to more than 200 assets and adds seven new commercial products Bolsters and diversifies Ligand’s long-term compounding growth, adding a complementary portfolio across development stages, therapeutic areas, and modalities to broaden patient access and improve lives Acquisition is expected to be immediately accretive to Ligand adjusted EPS; Ligand increases 2026 adjusted EPS guidance to $8.50-$9.501 and expects the transaction to be accretive by $1.50 per share to adjusted EPS in 2027 2 Ligand to hold investor call at 8:00 a.m. ET today JUPITER, Fla. and EMERYVILLE, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) and XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), both biotechnology royalty aggregators, today announced that the companies...

Continue reading

Apollo Funds to Acquire Forvia’s Automotive Interiors Business

Transaction to Establish Leading Global Automotive Interiors Supplier as Standalone Company NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds (the “Apollo Funds”) have agreed to acquire the Interiors Business Group of Forvia (“Interiors Business” or the “Company”), a leading global supplier of automotive interior systems, from Forvia SE (EPA: FRVIA) in a carve-out transaction. The Interiors Business is one of the world’s leading suppliers of automotive interior products including instrument panels, door panels and center consoles, and serves a diversified base of leading global automotive original equipment manufacturers (OEMs). With a global manufacturing and engineering footprint across Europe, North America and Asia, the Company is deeply embedded across a wide range of large-scale...

Continue reading

DarkIris Inc. Announces Closing of $3.8 Million PIPE Financing and $800,000 Content Asset Acquisition, Launching Full-Scale AIGC “Gaming + Film & Television” Ecosystem

HONG KONG, April 24, 2026 (GLOBE NEWSWIRE) — DarkIris Inc. (Nasdaq: DKI) (the “Company” or “DarkIris”), a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games through various third-party digital storefronts, today announced the successful closing of a series of previously disclosed private placement and intellectual property (IP) assets acquisition. These include a $3.8 million private investment in public equity (PIPE) financing and an approximately $800,000 content acquisition of premium film and television IPs through equity issuance. Through these transactions, DarkIris has introduced key industry partners into its business ecosystem, establishing a foundational collaboration framework to advance its AI-generated content (AIGC) closed-loop strategy across gaming and...

Continue reading

Form 8.3 – Advanced Medical Solutions Group

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Advanced Medical Solutions Group plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For...

Continue reading

Emerita Forms Special Committee, Engages Canaccord Genuity and Confirms Receipt of a Second Unsolicited Offer Letter From Denarius Metals

TORONTO, April 24, 2026 (GLOBE NEWSWIRE) — Emerita Resources Corp. (“Emerita” or the “Company”) (TSXV: EMO) (OTCQX: EMOTF) (FSE: LLJA) has formed a special committee comprised of independent directors (the “M&A Committee”) in response to the unsolicited offer letter received from Denarius Metals Corp. (“Denarius”) on April 10, 2026 (the “First Offer Letter”) to acquire all of the issued and outstanding common shares of Emerita (please see the Company’s press releases dated April 13, 2026 and April 21, 2026). The M&A Committee will consider and evaluate strategies to maximize shareholder value, including pursuing one or more strategic transactions and continuing to execute on the Company’s existing business plan. Emerita has engaged Canaccord Genuity Corp. (“Canaccord Genuity”) as financial advisor to the Company. Emerita...

Continue reading

AtlasClear Holdings Signs Letter of Intent to Acquire Ark Financial Services, Inc. together with its wholly owned subsidiary, Dawson James Securities, Inc.

Acquisition Adds Investment Banking and Capital Markets Origination to AtlasClear’s Correspondent-Clearing Platform through Wilson-Davis & Co., Inc. Combined Business Expected to Operate at Approximately $45 Million in Annualized Revenue and Approximately $5 Million in operating Net IncomeTAMPA, Fla., April 24, 2026 (GLOBE NEWSWIRE) — AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”) today announced that it has entered into a Letter of Intent to acquire Ark Financial Services, Inc. together with its wholly owned subsidiary, Dawson James Securities, Inc. (“Dawson James”), a full-service investment bank headquartered in Boca Raton, Florida. The acquisition is expected to be accretive in the first year. The aggregate purchase is payable in a combination of cash and AtlasClear common stock, with...

Continue reading

OIO Group Completes De Tomaso Business Combination, Establishing New Control and Strategic Platform for Growth

SINGAPORE, April 23, 2026 (GLOBE NEWSWIRE) — OIO Group (NASDAQ: OIO) (“OIO” or the “Company”) today announced the completion of its previously announced business combination with De Tomaso Automobili Holdings Limited (“De Tomaso”), resulting in a change of control of the Company. This milestone represents a transformational step for OIO as it advances its strategy to build a portfolio of distinctive, high-value operating businesses anchored in brand heritage, engineering excellence, and long-term value creation. As a result of the closing of the transaction, De Tomaso’s founder, Norman Choi, becomes the controlling shareholder of OIO Group, positioning the Company under leadership with deep expertise in luxury performance automotive, brand development, and global market expansion. Mr. Choi is expected to assume the roles of Chief...

Continue reading

MLG Capital Announces Acquisition of Crosslakes Industrial Portfolio in Grand Rapids MSA

BROOKFIELD, Wis., April 23, 2026 (GLOBE NEWSWIRE) — MLG Capital – a national leader in private real estate investments, announced today the acquisition of the Crosslakes Industrial Portfolio, a five-property industrial portfolio across the Grand Rapids, Walker, and Norton Shores submarkets in West Michigan. The Crosslakes Industrial Portfolio consists of functional, institutional‑quality industrial assets featuring a mix of multi‑tenant and single‑tenant buildings. Located within the Grand Rapids MSA, the portfolio benefits from proximity to major transportation infrastructure, including Interstate 96, U.S. Route 131, and Gerald R. Ford International Airport, providing strong regional and national connectivity. The market is supported by a diversified manufacturing employment base and limited new industrial supply, contributing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.